tecentriq.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * SITEMAP: https://www.tecentriq.com/sitemap.xml | ||
Meta Tags
| Title | Cancer Immunotherapy Treatment for NSCLC, ES-SCLC, HCC, Advanced Melanoma & mUC | TECENTRIQ® |
| Description | TECENTRIQ MAY WORK WITH YOUR IMMUNE SYSTEM TO FIGHT Learn about TECENTRIQ® (atezolizumab), a cancer Immunotherapy treatment for Non-Small Cell Lung Cancer after surgery and chemo, Metastatic Non-Small Cell Lung Cancer (NSCLC), Extensive-Stage Small Cell Lung Cancer (ES-SCLC), Liver cancer (HCC), |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.18.10.46 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
tecentriq.com Valuation
|
US$58,642,697
Last updated: 2022-06-24 06:28:54
tecentriq.com has Semrush global rank of 180,488. tecentriq.com has an estimated worth of US$ 58,642,697, based on its estimated Ads revenue. tecentriq.com receives approximately 6,766,465 unique visitors each day. Its web server is located in United States, with IP address 104.18.10.46. According to SiteAdvisor, tecentriq.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$58,642,697 |
| Daily Ads Revenue | US$54,132 |
| Monthly Ads Revenue | US$1,623,952 |
| Yearly Ads Revenue | US$19,487,420 |
| Daily Unique Visitors | 451,098 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tecentriq.com. | A | 300 | IP: 104.18.10.46 |
| tecentriq.com. | A | 300 | IP: 104.18.11.46 |
| tecentriq.com. | AAAA | 300 | IPV6: 2606:4700::6812:a2e |
| tecentriq.com. | AAAA | 300 | IPV6: 2606:4700::6812:b2e |
| tecentriq.com. | NS | 86400 | NS Record: lara.ns.cloudflare.com. |
| tecentriq.com. | NS | 86400 | NS Record: alan.ns.cloudflare.com. |
| tecentriq.com. | TXT | 300 | TXT Record: v=spf1 -all |
| tecentriq.com. | TXT | 300 | TXT Record: n7d1vl9tzbd8kp5wg6t9r3sywkvsm0r7 |
HtmlToTextCheckTime:2022-06-24 06:28:54
| Prescribing Information For US Healthcare Professionals Medication Guide Medication Guide Prescribing Information Prescribing Information Safety Safety MENU Medication Guide Safety For US Healthcare Professionals TECENTRIQ MAY WORK WITH YOUR IMMUNE SYSTEM TO FIGHT CANCER PLEASE SELECT CANCER TYPE: PLEASE SELECT CANCER TYPE: Non-Small Cell Lung Cancer Extensive-Stage Small Cell Lung Cancer Liver Cancer Advanced Melanoma Advanced Bladder Cancer TECENTRIQ MAY WORK WITH YOUR IMMUNE SYSTEM TO FIGHT CANCER PLEASE SELECT CANCER TYPE: PLEASE SELECT CANCER TYPE: Non-Small Cell Lung Cancer Extensive-Stage Small Cell Lung Cancer Liver Cancer Advanced Melanoma Advanced Bladder Cancer TECENTRIQ may also affect normal cells. Important Safety Information Back to Top Indications TECENTRIQ is a prescription medicine used to treat adults with: A type of bladder and urinary tract cancer called urothelial carcinoma. TECENTRIQ may be used when your bladder cancer has spread or cannot be removed by |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sun, 24 Oct 2021 17:01:41 GMT Connection: keep-alive Cache-Control: max-age=3600 Expires: Sun, 24 Oct 2021 18:01:41 GMT Location: https://tecentriq.com/ Set-Cookie: __cfruid=ec176852822def82f0c66047a48277b27e3e1128-1635094901; path=/; domain=.tecentriq.com; HttpOnly Server: cloudflare CF-RAY: 6a34c4bc7841f253-ORD HTTP/2 301 date: Sun, 24 Oct 2021 17:01:41 GMT content-type: text/html; charset=iso-8859-1 location: https://www.tecentriq.com/ cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cfruid=ec176852822def82f0c66047a48277b27e3e1128-1635094901; path=/; domain=.tecentriq.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6a34c4bcdd332a3c-ORD HTTP/2 200 date: Sun, 24 Oct 2021 17:01:41 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cfruid=ec176852822def82f0c66047a48277b27e3e1128-1635094901; path=/; domain=.tecentriq.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6a34c4bf09f42bb3-ORD |
tecentriq.com Whois Information
Domain Name: TECENTRIQ.COM Registry Domain ID: 1883029341_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2021-03-22T13:44:43Z Creation Date: 2014-10-31T09:36:33Z Registry Expiry Date: 2022-10-31T09:36:33Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ALAN.NS.CLOUDFLARE.COM Name Server: LARA.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T23:31:20Z <<< |